Thank you, Russell. This quarter, we had strong organic sales growth of 6.9%, while improving our gross profit margins and reducing our G&A expense as a percentage of sales, resulting in earnings growth and a quarterly record GAAP EPS of $1 per share, which was up 23.5%, compared to the fourth quarter of last year. Non-GAAP EPS, which is calculated as our GAAP EPS less the after tax impact of amortization expense was $1.04 per share this quarter, which was up 19.5% over the fourth quarter of last year. Both regions performed extremely well with strong sales and profit growth, compared to last year’s fourth quarter our Americas and Asia region grew organic sales 5.6% and increased segment profit by 17.2%, and our Europe and Australia region grew organic sales 9.5% and increased segment profit by 9.1%. Our teams are executing extremely well throughout our global businesses. So the key financial takeaways this quarter are strong revenue growth, record EPS, excellent performance within both of our regions, and a continued commitment to return funds to our shareholders. Let's move to slide number four for our quarterly sales trends. Organic sales grew 6.9% and foreign currency translation increased sales 0.6% this quarter, while the impact of our premises divestiture that we closed in the third quarter reduced sales by 0.7%, resulting in total sales growth this quarter. The recent weaking of the U.S. dollar versus other major currencies resulted in a slight positive to our total sales growth this quarter, which follows six consecutive quarters of the opposite FX impact due to the strengthening U.S. dollar. On slide number five, you'll find our quarterly gross profit margin trending. Our gross profit margin increased 40 basis points to 50.8%, compared to 50.4% in the fourth quarter of last year. Consistent with the third quarter, we were able to offset the majority of our input cost increases through reduced freight charges and other efficiency gains. Slide number six details our SG&A expense trending. SG&A was $97.5 million this quarter, compared to $94.5 million in the fourth quarter of last year. As a percent of sales SG&A declined to 28.2%, compared to 29.2% of sales in the fourth quarter of last year. If you exclude amortization expense from each of the periods presented, then SG&A will decrease from 28% of sales in the fourth quarter of last year to 27.5% of sales this quarter. So overall, we're making nice progress with our cost structure. We've reduced our SG&A expense from over 36% of sales seven years ago to 27.8% in the full-year fiscal 2023. Meanwhile, we're still investing in sales generating resources by growing our sales force, while identifying ongoing efficiency opportunities throughout our sales and other support functions. Slide number seven details the trending of our investments in research and development. This quarter, we once again increased our investment in R&D to $16.3 million, which was 4% of sales. We believe that the investments with the best ROI are almost always organic investments in particular research and development. We're committed to new product development and we have an exciting pipeline of new products set to launch in fiscal 2024. On slide number eight, pretax earnings increased 18.2% on a GAAP basis from $54 million to $63.8 million. And if you exclude amortization from both periods pretax earnings increased 14.8% on a non-GAAP basis from $57.7 million to $66.2 million. Slide number nine details the trending of earnings and EPS. You can see a clear trend of increasing earnings, and you can also see that the fourth quarter is our strongest quarter on record. On both a GAAP and non-GAAP basis, our fourth quarter EPS was an all-time record high. This quarter's GAAP EPS increased by 23.5%. And if you exclude the after tax impact of amortization from both periods, our fourth quarter non-GAAP EPS increased by 19.5%, compared to last year. On slide number 10, you'll find a summary of our cash generation. Operating cash flow increased substantially this quarter from $53.2 million in Q4 of last year to $79.3 million this quarter. And free cash flow increased as well from $32.2 million in last year's fourth quarter to $73 million this quarter. Operating cash flow was 161% of net income and free cash flow was 148% of net income this quarter. Turning to slide number 11, you can see the impacts that Brady's historical cash generation has had on our balance sheet. We're currently in a net cash position of $101.8 million. To put this in perspective, even with returning more than $56 million to shareholders in the form of dividends and buybacks this quarter, we still increased our net cash position by more than $17 million. Our approach to capital allocation is to first use our cash to fully fund organic sales and efficiency opportunities. This includes investing in new product development, sales generating resources, capability enhancing capital expenditures, and automation focused CapEx. Despite the economic -- and any on the economic uncertainty, we'll continue to deploy capital to drive productivity and sales growth. And second we focused on consistently increasing our dividend. We’ve now increased our dividends annually for 38 consecutive years, which is a streak that we're very proud of. After fully funding organic investments and dividends, we then deploy our cash in a disciplined manner for either acquisitions where we have clear synergies or for opportunistic buybacks when we see a disconnect between intrinsic value and Brady's trading price. Our strong balance sheet positions us to be able to execute additional value enhancing activities, such as R&D investments, and other organic sales opportunities to acquire companies strategically when the price is right and the synergies are clear, and to return funds to our shareholders through dividends and share buybacks. Slide number 12 provides an overview of our financial results for the full-year ended July 31, 2023. Overall, sales increased 2.3% and organic sales grew 5.5%. This organic sales growth was partially offset by the negative impact of foreign currency translation of 3% and a decline of 0.2%, due to the sale of our premises business in the third quarter. We finished fiscal 2023 with all time high GAAP and non-GAAP EPS. These strong earnings results were even after increasing our investment in R&D by nearly 5% this year. Fiscal 2023 was another record EPS year and our fourth quarter was another record quarter as well. We're confident that our actions this year and our consistent priorities will set us up for success in the future. So this takes us to our guidance for next year on slide number 13. We're forecasting GAAP EPS to range from $3.70 to $3.95 per share in fiscal 2024, which would represent an increase of 5.4% to 12.5% next year. We also anticipate organic sales growth in the mid-single-digit percentages for the year ending July 31, 2024. And based on foreign currency exchange rates as of July 31, we expect the weakening of U.S. dollar to increase fiscal ’24 sales by an additional -- approximately 2%. Other elements of our guidance include an income approximately 22%, depreciation and amortization expense of approximately $32 million to $34 million and capital expenditures of approximately $75 million. Our CapEx estimate is inclusive of the purchase of a previously leased facility and the build out of a new facility, totaling approximately $55 million. Our capital allocation strategy remains unchanged, which are to continue to invest in our organic business through both research and development and our sales force; continue to pay the dividend, which we just mentioned, increased for the 38th consecutive year; continue to be opportunistic with share buybacks, while identifying potential acquisitions where the price is right and the strategic fit is clear. We have a strong balance sheet and we'll continue to use it to drive long-term shareholder value. Potential risks to our guidance among others include potential strengthening of the U.S. dollar inflationary pressures that were unable to offset in a timely enough manner or an overall slowdown in economic activity. I'll now turn the call back over to Russell to cover our regional results and to provide some closing thoughts before Q&A. Russell.